Ethyl piperazine-2-carboxylate dihydrochloride

Catalog No. :
ACMKJG320
CAS No. :
129798-91-0
Molecular Formula :
C7H16Cl2N2O2
Molecular Weight :
231.12

IUPAC Name:ethyl piperazine-2-carboxylate dihydrochloride

Ethyl piperazine-2-carboxylate dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$79.00Login to see priceIn stockInquiry
25g97%$186.00Login to see priceIn stockInquiry
100g97%$596.00Login to see priceIn stockInquiry
500g97%$2465.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl piperazine-2-carboxylate dihydrochloride
IUPAC Nameethyl piperazine-2-carboxylate dihydrochloride
MDL No.MFCD22381964
Molecular FormulaC7H16Cl2N2O2
Molecular Weight231.12
SMILESO=C(C1NCCNC1)OCC.[H]Cl.[H]Cl
InChI KeyXUILSFCCCIHPIE-UHFFFAOYSA-N
SynonymEthyl Piperazine-2-carboxylate Dihydrochloride | 129798-91-0 | 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride | ethyl piperazine-2-carboxylate;dihydrochloride | Ethyl piperazine-2-carboxylate diHCl | 2-Piperazinecarboxylic acid, ethyl ester, hydrochlorid
CAS No.129798-91-0
PubChem CID11253230

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMKJG320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACDWIM392 route compound structure diagram
    ACDWIM3922762-32-5 In Stock
  4. Then
  5. ACMKJG320 route product structure diagram
    ACMKJG320129798-91-0 In Stock
Inquiry

2. ACMKJG320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMKJG320 route product structure diagram
    ACMKJG320129798-91-0 In Stock
Inquiry

Comments (0)